retatrutide clinical trial locations Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide Phase 3: TRIUMPH Program

Both medications typically require several weeks before significant weight loss becomes noticeable and several months before major results occur

All dosage information below comes from published clinical trial data

Conclusion Taking too much tirzepatide is a serious matter that can lead to severe gastrointestinal distress and dehydration

Common side effects include nausea and vomiting (slightly more common with the pill version), diarrhoea and/or constipation and abdominal discomfort, but these generally settle once people get used to the medicine

Weight-Related Conditions People with obesity-related conditions, such as type 2 diabetes or metabolic health concerns, are also being studied to understand potential benefits